These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 23298964)
41. Cholesteryl ester transfer protein inhibition: effect on reverse cholesterol transport? Rensen PC; Havekes LM Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):681-4. PubMed ID: 16556861 [No Abstract] [Full Text] [Related]
42. Cardiovascular disease in rheumatoid arthritis: disease and treatment interactions and their implications on treatment decisions. Sanders S; Geraci SA J Miss State Med Assoc; 2010 Mar; 51(3):75-80. PubMed ID: 20827876 [TBL] [Abstract][Full Text] [Related]
43. Unresolved issue: should patients with RA and a history of malignancy receive anti-TNF therapy? Brar A; Hiebert T; El-Gabalawy H Nat Clin Pract Rheumatol; 2007 Mar; 3(3):120-1. PubMed ID: 17334334 [No Abstract] [Full Text] [Related]
44. Anti-inflammatory drugs and tumor necrosis factor-alpha production from monocytes: role of transcription factor NF-kappa B and implication for rheumatoid arthritis therapy. Lavagno L; Gunella G; Bardelli C; Spina S; Fresu LG; Viano I; Brunelleschi S Eur J Pharmacol; 2004 Oct; 501(1-3):199-208. PubMed ID: 15464079 [TBL] [Abstract][Full Text] [Related]
45. Tumor necrosis factor-α blockade, cardiovascular outcomes, and survival in rheumatoid arthritis. Al-Aly Z; Pan H; Zeringue A; Xian H; McDonald JR; El-Achkar TM; Eisen S Transl Res; 2011 Jan; 157(1):10-8. PubMed ID: 21146146 [TBL] [Abstract][Full Text] [Related]
46. Mechanisms for modulating TNF alpha in immune and inflammatory disease. Baugh JA; Bucala R Curr Opin Drug Discov Devel; 2001 Sep; 4(5):635-50. PubMed ID: 12825458 [TBL] [Abstract][Full Text] [Related]
47. Rheumatoid arthritis and herpes zoster: risk and prevention in those treated with anti-tumour necrosis factor therapy. Winthrop KL; Furst DE Ann Rheum Dis; 2010 Oct; 69(10):1735-7. PubMed ID: 20858622 [No Abstract] [Full Text] [Related]
48. [Treatment of rheumatoid arthritis by inhibition of tumor necrosis factor with infliximab or etanercept]. Verhoeven AC; Boers M Ned Tijdschr Geneeskd; 2001 Nov; 145(47):2294-5. PubMed ID: 11760611 [No Abstract] [Full Text] [Related]
49. Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy. Mäki-Petäjä KM; Hall FC; Booth AD; Wallace SM; Yasmin ; Bearcroft PW; Harish S; Furlong A; McEniery CM; Brown J; Wilkinson IB Circulation; 2006 Sep; 114(11):1185-92. PubMed ID: 16952987 [TBL] [Abstract][Full Text] [Related]
50. Anti-tumor necrosis factor alpha therapy and the risk of lymphoma in rheumatoid arthritis: no clear answer. Symmons DP; Silman AJ Arthritis Rheum; 2004 Jun; 50(6):1703-6. PubMed ID: 15188344 [No Abstract] [Full Text] [Related]
51. Atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus. Haque S; Mirjafari H; Bruce IN Curr Opin Lipidol; 2008 Aug; 19(4):338-43. PubMed ID: 18607179 [TBL] [Abstract][Full Text] [Related]
52. Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia: associations with prednisone, disease-modifying antirheumatic drugs, and anti-tumor necrosis factor therapy. Wolfe F; Caplan L; Michaud K Arthritis Rheum; 2006 Feb; 54(2):628-34. PubMed ID: 16447241 [TBL] [Abstract][Full Text] [Related]